CIRM Alpha Stem Cell Clinics: Collaboratively Addressing Regenerative Medicine Challenges

Catriona H.M. Jamieson; Maria T. Millan; Abla A. Creasey; Geoff Lomax; Mary E. Donohoe; Mark C. Walters; Mehrdad Abedi; Daniela A. Bota; John A. Zaia; John S. Adams

doi:10.1016/j.stem.2018.05.007

CIRM Alpha Stem Cell Clinics: Collaboratively Addressing Regenerative Medicine Challenges

Catriona H.M. Jamieson, Maria T. Millan, Abla A. Creasey, Geoff Lomax, Mary E. Donohoe, Mark C. Walters, Mehrdad Abedi, Daniela A. Bota, John A. Zaia, John S. Adams

Hematology and Oncology

Research output: Contribution to journal › Comment/debate › peer-review

3 Scopus citations

Abstract

The California Institute for Regenerative Medicine (CIRM) Alpha Stem Cell Clinic (ASCC) Network was launched in 2015 to address a compelling unmet medical need for rigorous, FDA-regulated, stem cell-related clinical trials for patients with challenging, incurable diseases. Here, we describe our multi-center experiences addressing current and future challenges. The California Institute for Regenerative Medicine (CIRM) Alpha Stem Cell Clinic (ASCC) Network was launched in 2015 to address a compelling unmet medical need for rigorous, FDA-regulated, stem cell-related clinical trials for patients with challenging, incurable diseases. Here, we describe our multi-center experiences addressing current and future challenges.

Original language	English (US)
Pages (from-to)	801-805
Number of pages	5
Journal	Cell Stem Cell
Volume	22
Issue number	6
DOIs	https://doi.org/10.1016/j.stem.2018.05.007
State	Published - Jun 1 2018

ASJC Scopus subject areas

Molecular Medicine
Genetics
Cell Biology

Access to Document

10.1016/j.stem.2018.05.007

Fingerprint Dive into the research topics of 'CIRM Alpha Stem Cell Clinics: Collaboratively Addressing Regenerative Medicine Challenges'. Together they form a unique fingerprint.

Cite this

CIRM Alpha Stem Cell Clinics : Collaboratively Addressing Regenerative Medicine Challenges. / Jamieson, Catriona H.M.; Millan, Maria T.; Creasey, Abla A.; Lomax, Geoff; Donohoe, Mary E.; Walters, Mark C.; Abedi, Mehrdad; Bota, Daniela A.; Zaia, John A.; Adams, John S.

In: Cell Stem Cell, Vol. 22, No. 6, 01.06.2018, p. 801-805.

Research output: Contribution to journal › Comment/debate › peer-review

@article{3a7f2aa3e17f4d279ac3257aaab3a8b5,

title = "CIRM Alpha Stem Cell Clinics: Collaboratively Addressing Regenerative Medicine Challenges",

abstract = "The California Institute for Regenerative Medicine (CIRM) Alpha Stem Cell Clinic (ASCC) Network was launched in 2015 to address a compelling unmet medical need for rigorous, FDA-regulated, stem cell-related clinical trials for patients with challenging, incurable diseases. Here, we describe our multi-center experiences addressing current and future challenges. The California Institute for Regenerative Medicine (CIRM) Alpha Stem Cell Clinic (ASCC) Network was launched in 2015 to address a compelling unmet medical need for rigorous, FDA-regulated, stem cell-related clinical trials for patients with challenging, incurable diseases. Here, we describe our multi-center experiences addressing current and future challenges.",

author = "Jamieson, {Catriona H.M.} and Millan, {Maria T.} and Creasey, {Abla A.} and Geoff Lomax and Donohoe, {Mary E.} and Walters, {Mark C.} and Mehrdad Abedi and Bota, {Daniela A.} and Zaia, {John A.} and Adams, {John S.}",

year = "2018",

month = jun,

day = "1",

doi = "10.1016/j.stem.2018.05.007",

language = "English (US)",

volume = "22",

pages = "801--805",

journal = "Cell Stem Cell",

issn = "1934-5909",

publisher = "Cell Press",

number = "6",

}

TY - JOUR

T1 - CIRM Alpha Stem Cell Clinics

T2 - Collaboratively Addressing Regenerative Medicine Challenges

AU - Jamieson, Catriona H.M.

AU - Millan, Maria T.

AU - Creasey, Abla A.

AU - Lomax, Geoff

AU - Donohoe, Mary E.

AU - Walters, Mark C.

AU - Abedi, Mehrdad

AU - Bota, Daniela A.

AU - Zaia, John A.

AU - Adams, John S.

PY - 2018/6/1

Y1 - 2018/6/1

N2 - The California Institute for Regenerative Medicine (CIRM) Alpha Stem Cell Clinic (ASCC) Network was launched in 2015 to address a compelling unmet medical need for rigorous, FDA-regulated, stem cell-related clinical trials for patients with challenging, incurable diseases. Here, we describe our multi-center experiences addressing current and future challenges. The California Institute for Regenerative Medicine (CIRM) Alpha Stem Cell Clinic (ASCC) Network was launched in 2015 to address a compelling unmet medical need for rigorous, FDA-regulated, stem cell-related clinical trials for patients with challenging, incurable diseases. Here, we describe our multi-center experiences addressing current and future challenges.

AB - The California Institute for Regenerative Medicine (CIRM) Alpha Stem Cell Clinic (ASCC) Network was launched in 2015 to address a compelling unmet medical need for rigorous, FDA-regulated, stem cell-related clinical trials for patients with challenging, incurable diseases. Here, we describe our multi-center experiences addressing current and future challenges. The California Institute for Regenerative Medicine (CIRM) Alpha Stem Cell Clinic (ASCC) Network was launched in 2015 to address a compelling unmet medical need for rigorous, FDA-regulated, stem cell-related clinical trials for patients with challenging, incurable diseases. Here, we describe our multi-center experiences addressing current and future challenges.

UR - http://www.scopus.com/inward/record.url?scp=85047211312&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047211312&partnerID=8YFLogxK

U2 - 10.1016/j.stem.2018.05.007

DO - 10.1016/j.stem.2018.05.007

M3 - Comment/debate

C2 - 29859170

AN - SCOPUS:85047211312

VL - 22

SP - 801

EP - 805

JO - Cell Stem Cell

JF - Cell Stem Cell

SN - 1934-5909

IS - 6

ER -